Differential effects of diet-induced dyslipidemia and hyperglycemia on mesenteric resistance artery structure and function in type 2 diabetes
- Kamakshi Sachidanandam,
- Jim R. Hutchinson,
- Mostafa M. Elgebaly,
- Erin M. Mezzetti,
- Mong Heng Wang,
- Adviye Ergul(corresponding author)
- University of Georgia,
- Medical College of Georgia,
Open access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Type 2 diabetes and dyslipidemia oftentimes present in combination. However, the relative roles of diabetes and diet-induced dyslipidemia in mediating changes in vascular structure, mechanics, and function are poorly understood. Our hypothesis was that addition of a high-fat diet would exacerbate small artery remodeling, compliance, and vascular dysfunction in type 2 diabetes. Vascular remodeling indices [media/lumen (M/L) ratio, collagen abundance and turnover, and matrix me- talloproteinase dynamics], mechanical properties (vessel stiffness), and reactivity to pressure and vasoactive factors were measured in third-order mesenteric arteries in control Wistar and type 2 diabetic Goto-Kakizaki (GK) rats fed either a regular or high-fat diet. M/L ratios, total collagen, and myogenic tone were increased in diabetes. Addition of the high-fat diet altered collagen patterns (mature versus new collagen) in favor of matrix accumulation. Addition of a high-fat diet caused increased constriction to endothelin-1 (0.1-100 nM), showed impaired vasorelaxation to both acetylcholine (0.1 nM-1 μM) and sodium nitroprusside (0.1 nM-1 μM), and increased cardiovascular risk factors in diabetes. These results suggest that moderate elevations in blood glucose, as seen in our lean GK model of type 2 diabetes, promote resistance artery remodeling resulting in increased medial thickness, whereas addition of a high-fat diet contributes to diabetic vascular disease predominantly by impairing vascular reactivity in the time frame used for this study. Although differential in their vascular effects, both hyperglycemia and diet-induced dyslipidemia need to be targeted for effective prevention and treatment of diabetic vascular disease.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 123-130 (8 pages)Journal (Volume, Issue Number)
Journal of Pharmacology and Experimental Therapeutics (Volume 328, Issue 1)Publication milestones
- Published - 01/2009
Publication status
ISSN
0022-3565Publication IDs
- Scopus: 59149094001
- PubMed: 18941121
